Nabumetone
- Product NDC
- 71205-378
- 11-digit product format
- 712050378
- Labeler code
- 71205
- Product ID
- 71205-378_9490d3f2-d162-41b9-aad7-23aea8f5a500
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumentone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA075280
- Marketing category
- ANDA
- Marketing start
- 2002-02-25
- Marketing end
- 2022-07-31
- Substance
- NABUMETONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71205-378-30 | 71205037830 | 30 TABLET in 1 BOTTLE (71205-378-30) | 30 tablet | 2020-01-03 | 2022-07-31 | No | No | Current |
| 71205-378-60 | 71205037860 | 60 TABLET in 1 BOTTLE (71205-378-60) | 60 tablet | 2020-01-03 | 2022-07-31 | No | No | Current |
| 71205-378-90 | 71205037890 | 90 TABLET in 1 BOTTLE (71205-378-90) | 90 tablet | 2020-01-03 | 2022-07-31 | No | No | Current |